Drugs / Gimeracil and Oteracil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03192735 | Sep 2017 → Nov 2019 | gastric cancer | Chang-Ming Huang, Prof. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gimeracil and Oteracil | “Gimeracil and Oteracil Porassium Capsules twice times a day,from day1-day 14,per os” NCT03192735 ↗ |
| Route | Oral | “Gimeracil and Oteracil Porassium Capsules twice times a day,from day1-day 14,per os” NCT03192735 ↗ |